• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by BIO-key International Inc.

    8/27/25 4:31:06 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    S-8 1 bkyi20250820_s8.htm FORM S-8 bkyi20250820_s8.htm

     

    As filed with the Securities and Exchange Commission on August 27, 2025

      Registration No. 333-_______

     



    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER THE SECURITIES ACT OF 1933

     


     

    BIO-KEY INTERNATIONAL, INC.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware

    (State or other jurisdiction of incorporation or organization)

    41-1741861

    (I.R.S. Employer Identification No.)

    101 Crawfords Corner Road

    Suite 4116

    Holmdel, NJ

    (Address of Principal Executive Offices)

    07733

    (Zip Code)

     


    BIO-key International, Inc.

    2023 Stock Incentive Plan, as Amended

    (Full title of the plan)

     

    Michael W. DePasquale

    Chief Executive Officer

    BIO-key International, Inc.

    101 Crawfords Corner Road

    Suite 4116

    Holmdel, NJ 07733

    (Name and address of agent for service)

     

    (732) 359-1100

    (Telephone number, including area code, of agent for service)

     

    Copies requested to:

    Vincent A. Vietti, Esquire

    Fox Rothschild LLP

    212 Carnegie Center

    Suite 400

    Princeton, NJ 08540

    (609) 896-3600

     


    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
      Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     



     

     

     

     

    EXPLANATORY NOTE

    BIO-key International, Inc. (the “Company” or the “Registrant”) has filed this Registration Statement on Form S-8 (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended, to register an additional 700,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), issuable pursuant to awards granted under the BIO-key International, Inc. 2023 Stock Incentive Plan, as amended (the “2023 Plan”). This share increase was approved by the Company’s Board of Directors, upon recommendation of the Compensation Committee, on June 18, 2025, and was approved and adopted by the Company’s stockholders on August 8, 2025. The Company previously filed with the SEC a Registration Statement on Form S-8 (Reg. No. 333-280497) to register the initial 333,334 shares of Common Stock available for issuance under the 2023 Plan, which prior Registration Statement, with the exception of Items 3 and 8 of Part II of such prior Registration Statement, is hereby incorporated by reference.

     

    All figures have been adjusted to reflect the 18-for-1 stock split effected on December 20, 2023.

     

     

     

     

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference.

     

    The Company hereby incorporates by reference into this Registration Statement the following documents which have been previously filed (not furnished) with the SEC (File No. 001-13463):

     

      (a)

    The Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on April 23, 2025;

     

      (b)

    The Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 filed with the SEC on May 15, 2025 and June 30, 2025 filed with the SEC on August 13, 2025;

     

     

    (c)

    The Company’s Current Reports on Form 8-K (other than portions thereof furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits accompanying such reports that are related to such items) filed with the SEC on January 16, 2025, April 24, 2025, May 15, 2025, August 13, 2025 and August 20, 2025; and

     

     

    (e)

    The description of the Common Stock contained in Exhibit 4.5 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on April 1, 2022 and any amendment or report filed for the purpose of updating such description.

     

    In addition, all other documents filed (not furnished) by the Company pursuant to Section 13(a), Section 13(c), Section 14 or Section 15(d) of the Securities Exchange Act of 1934, as amended, on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated in this Registration Statement by reference and to be a part of this Registration Statement from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished to and not filed with the SEC in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement.

     

    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

     

     

     

    Item 8. Exhibits.

     

    The following exhibits are filed with or incorporated by reference into this Registration Statement:

     

    Exhibit No.

     

    Description

         

    4.1

     

    Certificate of Incorporation of BIO-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on January 5, 2005)

       

    4.2

     

    Bylaws (incorporated by reference to Exhibit 3.3 to the current report on Form 8-K, filed with the SEC on January 5, 2005)

         

    4.3

     

    Certificate of Amendment to Certificate of Incorporation (incorporated by reference to Appendix A to the definitive proxy statement, filed with the SEC on January 18, 2006)

         

    4.4

     

    Certificate of Amendment of Certificate of Incorporation of Bio-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.4 to the annual report on Form 10-K, filed with the SEC on March 31, 2015)

         

    4.5

     

    Certificate of Elimination of BIO-key International, Inc. filed October 6, 2015 (incorporated by reference to Exhibit 3.5 to the registration statement on Form S-1 (File No. 333-208747), filed with the SEC on December 23, 2015)

         

    4.6

     

    Certificate of Designation of Preferences, Rights and Limitations of Series A-1 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on November 2, 2015)

         

    4.7

     

    Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the quarterly report on Form 10-Q, filed with the SEC on November 16, 2015)

         

    4.8

     

    Certificate of Amendment of Certificate of Incorporation of Bio-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on December 28, 2016)

         

    4.9

     

    Certificate of Amendment of Certificate of Incorporation of Bio-Key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on November 19, 2020)

         

    4.10

     

    Certificate of Amendment to Certificate of Incorporation of BIO-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on December 19, 2023)

         

    4.11

     

    Specimen Stock Certificate (incorporated by reference to Exhibit 4.1 to the registration statement on Form SB-2 (File No. 333-16451))

       

    5.1

     

    Opinion of Fox Rothschild LLP regarding the validity of the shares of Common Stock being registered (Filed herewith)

         

    23.1

     

    Consent of Bush & Associates CPA LLC (Filed herewith)

         

    23.3

     

    Consent of Fox Rothschild LLP (Included within the opinion filed as Exhibit 5.1)

       

    24.1

     

    Power of Attorney (Included on signature page to this Registration Statement)

     

     

     

     

    Exhibit No.   Description
         

    99.1

     

    BIO-key International, Inc. 2023 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the current report on Form 8-K, filed with the SEC on December 19, 2023)

         

    99.2

     

    Amendment No. 1 to the BIO-key International, Inc. 2023 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the current report on Form 8-K, filed with the SEC on August 20, 2025)

         

    107

     

    Filing Fee Table (Filed herewith)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Holmdel, State of New Jersey, on August 27, 2025.

     

     

    BIO-KEY INTERNATIONAL, INC.

     

     

     

     

     

     

     

     

     

     

    By:

    /s/ Michael W. DePasquale

     

     

    Michael W. DePasquale

     

     

    Chief Executive Officer

     

     

    POWER OF ATTORNEY

     

    We, the undersigned officers and directors of BIO-key International, Inc. hereby severally constitute and appoint Michael W. DePasquale and Cecilia Welch, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for each of the undersigned and in each of the undersigned’s name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as each of the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or any of their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Name and Signature

     

    Title

     

    Date

             

    /s/ Michael W. DePasquale

     

    Chairman of the Board of Directors, Chief Executive

    Officer and Director

    (Principal Executive Officer)

     

    August 27, 2025

    Michael W. DePasquale

           

    /s/ Cecilia Welch

     

    Chief Financial Officer and Secretary

    (Principal Financial and Accounting Officer)

     

    August 27, 2025

    Cecilia Welch

           
             

    /s/ Robert J. Michel

     

    Director

     

    August 27, 2025

    Robert J. Michel

           
             

    /s/ Wong Kwok Fong

     

    Director

     

    August 27, 2025

    Wong Kwok Fong

           
             

    /s/ Cameron Williams

     

    Director

     

    August 27, 2025

    Cameron Williams

           
             

    /s/ Manny Alia

     

    Director

     

    August 27, 2025

    Manny Alia

           

     

     
    Get the next $BKYI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Sullivan James David bought $7,700 worth of shares (10,000 units at $0.77), increasing direct ownership by 22% to 54,851 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    8/26/25 8:39:25 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Depasquale Michael W bought $3,900 worth of shares (5,000 units at $0.78), increasing direct ownership by 10% to 53,519 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    6/16/25 8:19:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Depasquale Michael W bought $3,320 worth of shares (4,000 units at $0.83), increasing direct ownership by 9% to 48,519 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    6/4/25 8:30:02 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $BKYI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bio-key upgraded by Maxim Group with a new price target

    Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

    3/26/21 7:52:25 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Q2'25 Revenue Rose 49% Driven by Increases Across All Three Segments; Launches "BIO-key CyberDefense Initiative" to Support Growing Global Investment in Military and Defense Preparedness; Investor Call 10am ET Today

    HOLMDEL, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless enhanced biometric authentication, announced results for its second quarter (Q2'25) and six months (6M'25) ended June 30, 2025. BIO-key is hosting an investor call today at 10:00am ET (details below). Q2 Key Highlights Foreign Defense Ministry Awarded BIO-key over $600K in Follow-On orders for Secure Biometric Access to Critical Information.BIO-key and Runlevel Secured First Major IAM Deployment with a National Bank in Mozambique, Extending a Growing

    8/13/25 8:30:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET

    HOLMDEL, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric authentication, will host its second quarter 2025 investor call on Wednesday, August 13th at 10 a.m. ET. Results will be released before the stock market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session. Call Details Date / Time:Call Dial In #:Live Webcast / Replay:Audio Replay:Wednesday, August 13th at 10 a.m. ET1-877-418-5460 U.S. or 1-412-717-9594 Int'lWebca

    8/5/25 7:59:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Joins ISMS Forum to Advance Cybersecurity and Identity Management Best Practices in Spain

    MADRID and HOLMDEL, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced that it has joined ISMS Forum, Spain's leading cybersecurity association dedicated to promoting information security, data protection, and risk management best practices. This collaboration reinforces BIO-key's expanding presence and commitment to enhancing cybersecurity resilience and contributing to the development of robust security strategies for organizations across Spain. Through its ISMS Forum membership, BIO-key will actively participate in a range of initiative

    6/25/25 7:58:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    SEC Filings

    View All

    SEC Form S-8 filed by BIO-key International Inc.

    S-8 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    8/27/25 4:31:06 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    8/20/25 4:32:11 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by BIO-key International Inc.

    10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    8/13/25 4:46:15 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Leadership Updates

    Live Leadership Updates

    View All

    BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

    DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien

    12/11/23 7:59:02 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Identity and Access Management Software Provider BIO-key Names Seasoned Financial Services Executive Cameron E. Williams to its Board of Directors

    WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has appointed Cameron E. Williams to its Board of Directors. Mr. Williams has spent over forty years in leading executive officer roles in banking and financial services firms, serving on the board of directors of multiple organizations and more recently, in founding and leading strategic, financial and security consulting firms. Mr. Williams brings deep experience, an ideal skill set, and a broad base of relationships to his role on BIO-key

    6/2/23 8:01:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Identity and Access Management Solutions Provider BIO-key Adds Proven Security Sales Leaders in Planned Senior Management Transition

    WALL, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced the appointment of Galen Rodgers, Vice President of Channels, and Chad Carter, VP North America Sales. The appointments are effective today, January 3, and are in anticipation of the planned retirement of Chief Revenue Officer Fred Corsentino. A top-performing technology leader, Galen Rodgers, who will report to Chairman & CEO Michael DePasquale, brings 20+ years of experience in channel program development, marketing strategy, value selling, management, cyber security, proces

    1/3/23 8:01:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Financials

    Live finance-specific insights

    View All

    BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET

    HOLMDEL, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric authentication, will host its second quarter 2025 investor call on Wednesday, August 13th at 10 a.m. ET. Results will be released before the stock market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session. Call Details Date / Time:Call Dial In #:Live Webcast / Replay:Audio Replay:Wednesday, August 13th at 10 a.m. ET1-877-418-5460 U.S. or 1-412-717-9594 Int'lWebca

    8/5/25 7:59:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

    HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

    5/15/25 4:15:00 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET

    HOLMDEL, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management solutions with unique Identity-Bound Biometric capabilities, will host its first quarter 2025 investor call on Friday, May 16th at 10 a.m. ET. Results will be released after market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call DetailsDate / Time: Friday, May 16th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 monthsAudio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 65

    5/9/25 11:00:08 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by BIO-key International Inc.

    SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    11/14/24 5:05:04 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by BIO-key International Inc.

    SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    2/14/24 3:30:35 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

    SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    2/13/24 8:04:15 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Sullivan James David bought $7,700 worth of shares (10,000 units at $0.77), increasing direct ownership by 22% to 54,851 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    8/26/25 8:39:25 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Depasquale Michael W was granted 139 shares, increasing direct ownership by 0.26% to 53,658 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    7/2/25 5:28:42 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Legal Officer Sullivan James David was granted 139 shares, increasing direct ownership by 0.31% to 44,851 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    7/2/25 5:24:40 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology